Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.

Claudia  Nickolaus

Head of Investor & Public Relations

Dr. Yann  Samson

Chairman of Supervisory Board & Sustainability Officer

Mr. Matthias  Gaertner

Chief Executive Officer & Chairman of the Executive Board

Mr. Falk  Neukirch

Chief Financial Officer & Member of Executive Board

Mr. Christoph  Prußeit

Chief Innovation Officer & Member of Executive Board

Ms. Mi-Young  Miehler

Chief Operating Officer & Member of Executive Board

Medios AG

Medios AG Structuur van het management

Informatie over het management